Discovery of JNJ-74856665: A Novel Isoquinolinone DHODH Inhibitor for the Treatment of AML
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c00809 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Lindsey G DeRatt und 17 weiteren Autor:innen. Beteiligte Einrichtung: Janssen Research and Development, Spring House, Pennsylvania 19477, United States. Hauptthemen laut MEDLINE: Dihydroorotate Dehydrogenase, Oxidoreductases Acting on CH-CH Group Donors, Leukemia, Myeloid, Acute, Enzyme Inhibitors. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Acute myelogenous leukemia (AML), a heterogeneous disease of the blood and bone marrow, is characterized by the inability of myeloblasts to differentiate into mature cell types. Dihydroorotate dehydrogenase (DHODH) is an enzyme well-known in the pyrimidine biosynthesis pathway and preclinical findings demonstrated that DHODH is a metabolic vulnerability in AML as inhibitors can induce differentiation across multiple AML subtypes. As a result of virtual screening and structure-based drug design approaches, a novel series of isoquinolinone DHODH inhibitors was identified. Further lead optimization afforded JNJ-74856665 as an orally bioavailable, potent, and selective DHODH inhibitor with favorable physicochemical properties selected for clinical development in patients with AML and myelodysplastic syndromes (MDS).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Janssen Research and Development, Spring House, Pennsylvania 19477, United States.
- Janssen Research and Development, Turnhoutseweg 30, B-2340 Beerse, Belgium.
ORCID-Profile: Lindsey G DeRatt, Zhuming Zhang, Justin S Cisar
Zitieren
APA
DeRatt, L. G., Zhang, Z., Pietsch, C., Cisar, J. S., Zhang, X., Wang, W., Tanner, A., Matico, R., Shaffer, P., Jacoby, E., Kazmi, F., Shukla, N., Bush, T. L., Patrick, A., Philippar, U., Attar, R., Edwards, J. P., & Kuduk, S. D. (2024). Discovery of JNJ-74856665: A Novel Isoquinolinone DHODH Inhibitor for the Treatment of AML. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00809
Vancouver
DeRatt LG, Zhang Z, Pietsch C, Cisar JS, Zhang X, Wang W, et al. Discovery of JNJ-74856665: A Novel Isoquinolinone DHODH Inhibitor for the Treatment of AML. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00809
BibTeX
@article{DeRatt2024,
author = {DeRatt, Lindsey G and Zhang, Zhuming and Pietsch, Christine and Cisar, Justin S and Zhang, Xiaochun and Wang, Weixue and Tanner, Alexandra and Matico, Rosalie and Shaffer, Paul and Jacoby, Edgar and Kazmi, Faraz and Shukla, Neetu and Bush, Tammy L and Patrick, Aaron and Philippar, Ulrike and Attar, Ricardo and Edwards, James P and Kuduk, Scott D},
title = {Discovery of JNJ-74856665: A Novel Isoquinolinone DHODH Inhibitor for the Treatment of AML},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c00809}
}
EUVIMED